MBX Biosciences, Inc. Common Stock
USD53.35
-0.50 (-0.93%)
CEO
Peter Kent Hawryluk
IPO Date
2000-01-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$54.24
Prev. Close
$53.85
Day Low
$53.27
Day High
$54.94
52W Low
$9.63
52W High
$55.00
Market Cap
$1.79B
Volume
0.04M
| -9.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 44.9% | -38.7% | -0.00 | 21.26 | -23.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 61.3% | -58.0% | -0.01 | 12.89 | -28.8 |
| -13.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -5.6% | -5.4% | 0.00 | 32.95 | -6.9 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -8.9% | -8.4% | 0.00 | 19.50 | -4.9 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -10.1% | -9.7% | 0.00 | 23.31 | -2.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -6.1% | -5.8% | 0.00 | 24.19 | -9.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -6.7% | -6.4% | 0.00 | 25.75 | -12.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 16.2% | -25.2% | -0.00 | 7.17 | -12.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -17.8% | -16.4% | 0.01 | 12.76 | -16.0 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 12.2% | -10.5% | -0.00 | 21.26 | -21.3 |